• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 817-827.DOI: 10.3969/j.issn.1671-2587.2026.05.021

• 综述 • 上一篇    下一篇

个体化输血策略中生理性指标的研究进展

肖艳丽, 李代红, 刘伟   

  1. 天津市第一中心医院输血科,天津 300192
  • 收稿日期:2026-09-02 修回日期:2026-09-20 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 刘伟,主要从事输血免疫学研究,(E-mail)liuwei2024@126.com。
  • 作者简介:肖艳丽,主要从事输血免疫学研究,(E-mail)xiaoyanli92@163.com。

Research Progress on Physiological Indicators in Individualized Transfusion Strategies

XIAO Yanli, LI Daihong, LIU Wei   

  1. Department of Blood Transfusion, Tianjin First Central Hospital, Tianjin 300192
  • Received:2026-09-02 Revised:2026-09-20 Online:2026-10-20 Published:2026-11-11

摘要: 红细胞输注是临床最常用的支持治疗之一,但单用血红蛋白(Hb)阈值难以反映患者复杂的氧输送与组织氧利用状态,特殊人群的证据也提示,红细胞限制性输注阈值并不普遍适用。本文以组织氧供需平衡的生理学为基础,系统综述个体化输血策略中生理性指标的研究进展:①组织氧合监测可无创、连续地反映器官氧合状态,但患者输血后的反应存在异质性,尚无法建立统一诊断阈值化;②乳酸及其清除率更适合作为“分层”与“趋势”判断工具,而非即时输血触发点。本文还梳理了特殊人群的个体化阈值探索与人工智能在输血决策中的应用等前沿方向,生理性指标导向是个体化输血的核心演进方向,但多数指标缺乏前瞻性验证与标准化界值。未来研究应聚焦多模态整合、闭环决策与硬终点前瞻性验证,使输血的获益-风险比趋于最优。

关键词: 个体化输血, 生理性指标, 组织氧合, 乳酸, 人工智能

Abstract: Red blood cell (RBC) transfusion is one of the most widely used supportive therapies in clinical practice. However, single hemoglobin (Hb) threshold poorly reflects the complex status of oxygen delivery and tissue oxygen utilization in individual patients, and evidence from special populations continues to challenge the universal applicability of RBC restrictive thresholds. Based on the physiology of oxygen supply-demand balance at the tissue level, this review summarizes recent advances in physiological indicators for individualized transfusion: 1) tissue oxygenation monitoring provides noninvasive and continuous information on organ oxygenation, but heterogeneous responses to transfusion make it difficult to establish universal thresholds; 2) lactate levels and its clearance rates are better suited as tools for stratification and trend assessment than transfusion triggers. Individualized thresholds for special populations and emerging directions such as artificial intelligence are also reviewed. Physiological indicator-guided transfusion represents the core direction in the evolution of individualized transfusion, but most indicators still lack prospective validation and standardized trigger values. Future research should focus on multimodal integration, closed-loop decision-making, and prospective validation with hard endpoints, so as to optimize the benefit-risk balance of transfusion.

Key words: Individualized transfusion, Physiological indicators, Tissue oxygenation, Lactate, Artificial intelligence

中图分类号: